- Total Pro Portfolios with NKTR:
- Perceptive Advisors LLC
- Eastbourne Capital
- show more
- Total Do-It-Yourself Portfolios with NKTR:
- Jeremiah Portfolio 1
- deborah Portfolio 1
- kan1
- AP Portfolio 1
- robins portfolio 2007
- eliot baum Portfolio 1
- goalee111 Portfolio 1
- Walterk55 Portfolio 1
- ttdiep Portfolio 1
- Ha
- judymcmullen Portfolio 1
- steven jossem
- rockman Portfolio 1
- bojdak Portfolio 1
- SUPER STOCK 07
- rickthorne Portfolio 1
- portfolioP
- dilgandhi Portfolio 1
- Led Zeppelin
- ihavnionu Portfolio 1
- ynot gorf Portfolio 1
- gzureikat
- warren129
- scjs4r speculative
- BlitzFund - Healthcare
- sonihaal Portfolio 1
- rasinvents Portfolio 1
- RatBastard Portfolio 1
- TEV5 Portfolio 1
- kamwong Portfolio 1
- spkidd Portfolio 1
- show more
- 62
- blog picks
- Claus U Portfolio 1
- Sportfolio
- ROBgelwick Portfolio 1
- nick koutovas Portfolio 1
- Joe Pistritto Portfolio 1
- SHANIA
- Raymond Nguyen Portfolio 1
- Individual Securities
- NCThinker
- dselby Portfolio 1
- stebalee Portfolio 1
- projectpat Portfolio 1
- A1ARICHIE Portfolio 1
- JerryForsyth Portfolio 1
- Doberman Portfolio 1
- BostonNJ Portfolio 1
- MK's Portfolio
- RLONGO Portfolio 1
- darinscron Portfolio 1
- josephsv Main Portfolio
- fed3 52 week low on 6-13-2007
- jehowe Portfolio 1
- Babbin
- ~Zorro Portfolio 1
- heydude
- SUPRATRADE NANOTECH 1607071621
- All in One Basket
- nelson4907 Portfolio 1
- ICounts
- PART 4 JPMorgan 26th Annual Healthcare Conf 1/8/08..2nd Day Reporting Companies..Nymph Take
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:Andy S |
Date:09 15 07 |
speculative. |
|
Not yet rated
Rate now:
|
|
By:Walterk55 |
Date:09 04 07 |
Look at the new board member and the new CFO; both brought on to prepare this company to be taken over. At what price? I think it is time to build a good position in NKTR. |
|
Not yet rated
Rate now:
|
|
By:Jaime Gracia |
Date:06 04 07 |
Partnered with PFE for Exubera |
|
Not yet rated
Rate now:
|
|
By:junklord |
Date:05 03 07 |
Limited downside; techology fits well in addressing impending diabetes crisis; Exubera will be a blockbuster drug!!! |
|
Not yet rated
Rate now:
|
|
By:MJC |
Date:02 09 07 |
Despite PFE woes, Exubera will take center stage. Expect rapid growth in scripts esp once DTC ads start in 2nd half. Could be profitable by Q4, but more likely early next year. Next generation bong to leapfrog comp. Cheap stock/takeover potential |
|
Not yet rated
Rate now:
|
|
Date:01 19 07 |
|
Hopeful that insulin inhaler would be competitive option for diabetics |
|
Not yet rated
Rate now:
|
|



